Top Story

RAI treatment may increase second primary malignancy risk among children, young adults with thyroid cancer

April 15, 2015

An elevated risk for second primary malignancy, especially salivary gland cancer, was found among pediatric and young adult patients who received radioactive iodine for differentiated thyroid cancer, according to recent study findings published in Thyroid.

“The use of adjuvant radioactive iodine therapy in patients with thyroid cancer is known to be associated with an escalated risk of second primary malignancies,” the researchers wrote. “This risk has been quantified in several large studies of adult patients. Risks have not been well defined in the pediatric population, due to the relative rarity of this cancer in this population.”

In the Journals

GH therapy appears safe in children without risk factors for cancer

April 14, 2015
In children without known risk factors for developing cancer, the use of growth hormone therapy appears to be safe and does not confer an increased risk for subsequent…
In the Journals

MRD monitoring may guide risk-based therapy in pediatric ALL

April 10, 2015
The sequential monitoring of minimal residual disease levels during remission induction in pediatric patients with acute lymphoblastic leukemia may help guide treatment…
In the Journals

HSCT outcomes similar in pediatric ALL regardless of donor type

April 6, 2015
 Pediatric patients with high-risk acute lymphoblastic leukemia who underwent hematopoietic stem cell transplantation with matched unrelated donors demonstrated…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
In the Journals

RAI treatment may increase second primary malignancy risk among children, young adults with thyroid cancer

April 15, 2015
An elevated risk for second primary malignancy, especially salivary gland cancer, was found among pediatric and young adult patients who received…
In the Journals

GH therapy appears safe in children without risk factors for cancer

April 14, 2015
In children without known risk factors for developing cancer, the use of growth hormone therapy appears to be safe and does not confer an increased…
In the Journals

MRD monitoring may guide risk-based therapy in pediatric ALL

April 10, 2015
The sequential monitoring of minimal residual disease levels during remission induction in pediatric patients with acute lymphoblastic leukemia may…
In the Journals

HSCT outcomes similar in pediatric ALL regardless of donor type

April 6, 2015
 Pediatric patients with high-risk acute lymphoblastic leukemia who underwent hematopoietic stem cell transplantation with matched unrelated…
In the Journals

Morbidity increases among childhood cancer survivors

April 1, 2015
The projected increase in the number of survivors of childhood cancer has corresponded with an increase in the morbidity burden of this population…
In the Journals

Aprepitant effective for CINV prevention in children

March 30, 2015
The addition of aprepitant to ondansetron effectively reduced or prevented chemotherapy-induced nausea and vomiting in pediatric patients who…
In the Journals

Genomic maps could improve pediatric adrenocortical tumor identification, treatment

March 16, 2015
Genomic maps of pediatric adrenocortical tumors have revealed aberrant genetic and chromosomal changes that drive cancer, along with the sequence of…
In the Journals

Pediatric germ cell tumor incidence varied by gender, age; survival high

March 16, 2015
The localization and histology of pediatric germ cell tumors varied between genders and age groups, with an increased incidence rate observed only in…
Richard Pazdur, MD FDA News

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 10, 2015
The FDA today announced the approval of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma, according to a press…
William E. Evans, PharmD In the Journals

Inherited gene variant increases neuropathy risk in children with ALL

March 9, 2015
Children with acute lymphoblastic leukemia who had an inherited polymorphism in the promoter region of CEP72 demonstrated a greater risk for…
More Headlines »
morganatic-roan
morganatic-roan